Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 23, 2023 - Issue 8: Biosimilars
Submit an article Journal homepage
1,172
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)

Bernd Bokemeyera Interdisciplinary Crohn Colitis Centre Minden, Minden, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2016-6991View further author information
ORCID Icon,
Tibor Hlavatyb 5th Department of Internal Medicine, Sub-department of Gastroenterology and Hepatology, University Hospital Bratislava and Comenius University, Bratislava, SlovakiaView further author information
,
Matthieu Allezc Gastroenterology Department, Hôpital Saint-Louis - APHP, INSERM U1160, Université De Paris, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-2012-7522View further author information
ORCID Icon,
Pamela Selemad Worldwide Safety and Risk Management, Pfizer, Inc, New York City, NY, USAView further author information
,
Shahrzad Moosavid Worldwide Safety and Risk Management, Pfizer, Inc, New York City, NY, USAView further author information
,
Mary Jane Cadatale Global Biometrics and Data Management, Pfizer, Inc, Manila, PhilippinesView further author information
,
Heather Fowlerf Clinical Development and Operations, Pfizer, Inc, London, UKView further author information
,
Markus Muellerg Medical Affairs, Pfizer, Pharma GmbH, Berlin, GermanyView further author information
,
Katherine F Liauh Biosimilars, Pfizer, Inc, La Jolla, CA, USAView further author information
&
Javier P Gisberti Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, SpainORCID Iconhttps://orcid.org/0000-0003-2090-3445View further author information
ORCID Icon show all
Pages 791-800 | Received 29 Sep 2022, Accepted 05 Apr 2023, Published online: 16 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.